New questions are being raised about the clinical trial of a widely used heart drug, and critics are calling for an independent investigation, after a medical device used during the study was later ...

People with the heart rhythm disorder atrial fibrillation may have a heightened risk of developing dementia-- and the quality of their drug treatment may play a role, a new study hints. Specifically, ...

Warfarin (Coumadin) may not be the best oral anticoagulant in atrial fibrillation (Afib) in terms of bone health, a retrospective study suggested. On multivariable-adjusted, propensity score-matched ...

One doctor offers answers to your questions about genetic testing and Coumadin. Aug. 17, 2007 — -- Thursday night on "World News," we asked for your questions regarding the new genetic testing ...

I and every other clinician who treats patients with the common blood thinner warfarin (Coumadin) have a problem. The effect of the drug is delayed. If gauging the effect of the drug wasn’t difficult ...

October 24, 2006 (Toronto, ON) - Substitution of generic warfarin for brand-name warfarin (Coumadin, Bristol-Myers Squibb) has no appreciable effect on rates of INR testing or hospitalization for ...

Oct. 27, 2004 (Seattle) — Patients who are in sinus rhythm after mitral valve repair are not at risk for stroke and therefore do not require the standard three-month course of warfarin (Coumadin) ...

In Coumadin banter, lessons for marketers of new blood thinners A love-hate relationship for Coumadin (warfarin) is playing out online, say authors of a new report that may offer lessons for marketers ...

The anti-clotting drug warfarin, commonly known by the brand name Coumadin, is no longer recommended for the treatment of atrial fibrillation except for a select subset of patients, according to ...

Recent safety concerns among Pradaxa users, their families and some doctors, has caused the Food and Drug Administration to issue a safety review on Friday stating that the risk of serious bleeding in ...